Evidence map›Paper›PMID 30714579›Full record

ArticleRMD open2018

EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology.

Christian Dejaco, Polina Putrik, Julia Unger, Daniel Aletaha, Gerolamo Bianchi, Johannes W Bijlsma, Annelies Boonen, Nada Cikes, Axel Finckh, Laure Gossec and 10 more

Abstract read
In one paragraph

Article in RMD open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Christian DejacoDepartment of Rheumatology and Immunology, Medical University Graz, Graz, Austria.ORCID 0000-0002-0173-0668
Polina PutrikDepartment of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Julia UngerDepartment of Health Studies, FH JOANNEUM, University of Applied Sciences, Bad Gleichenberg, Austria.
Daniel AletahaDivision of Rheumatology, Medical University Vienna, Vienna, Austria.
Gerolamo BianchiDivision of Rheumatology, ASL3-Azienda Sanitaria Genovese, Genova, Italy.
Johannes W BijlsmaDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Annelies BoonenDepartment of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Nada CikesDivision of Clinical Immunology & Rheumatology, School of Medicine, University of Zagreb, Zagreb, Croatia.
Axel FinckhDivision of Rheumatology, Department of Internal Medicine Specialities, Geneva University Hospital, Geneva, Switzerland.
Laure GossecRheumatology Department, Pitié Salpêtrière hospital, APHP, Paris, France.
Tore K KvienDepartment of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
Joao Madruga DiasDepartment of Rheumatology, Centro Hospitalar Médio Tejo, Torres Novas, Portugal.
Eric L MattesonDivision of Rheumatology and Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, United States.
Francisca SiveraDepartment of Rheumatology, Hospital General Universitario de Elda, Elda, Spain.
Tanja A StammSection for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-3073-7284
Zoltan SzekaneczFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, University of Debrecen, Debrecen, Hungary.
Dieter WiekEULAR Standing Committee of PARE, Zurich, Switzerland.
Angela ZinkDeutsches Rheuma-Forschungszentrum, Berlin, Germany.
Sofia Ramiro *Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands.
Frank Buttgereit *Department of Rheumatology and Clinical Immunology, Charitè University Hospital, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCurrent methods used for forecasting workforce requirements in rheumatology are disparate, as are the parameters incorporated into workforce projection studies. The objective of these European League Against Rheumatism (EULAR points to consider (PTC) is to guide future workforce studies in adult rheumatology in order to produce valid and reliable manpower estimates.

methodsThe EULAR Standardised Operating Procedures were followed. A multidisciplinary task force with experts including patients with rheumatic diseases from 11 EULAR countries and the USA was assembled. A systematic literature review (SLR) was conducted to retrieve workforce models in rheumatology and other medical fields. PTC were based on expert opinion informed by the SLR, followed by group discussions with consensus obtained through informal voting. The level of agreement with the PTC was voted anonymously.

resultsA total of 10 PTC were formulated. The task force recommends models integrating supply (=workforce available in rheumatology), demand (=health services requested by the population) and need (=health services that are considered appropriate to serve the population). In general, projections of workforce requirements should consider all factors relevant for current and future workload in rheumatology inside and outside of direct patient care. Forecasts of workforce supply should consider demography and attrition of rheumatologists, as well as the effects of new developments in healthcare. Predictions of future need/demand should take demographic, sociocultural and epidemiological development of the population into account.

conclusionThese EULAR-endorsed PTC will provide guidance on the methodology and the parameters to be applied in future national and international workforce requirement studies in rheumatology.

Indexed as

arthritisepidemiologyhealth services research

Identifiers

PMID30714579
PMCPMC6336096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.